Retatrutide is a research peptide studied for its activity as a triple hormone receptor agonist (GLP-1, GIP, and glucagon receptors), with potential applications in metabolic and obesity research. It is intended for research purposes only and is not approved for human therapeutic use.
€ 89.99 – € 199.99Price range: € 89.99 through € 199.99
Third-Party Tested by Janoshik Analytical
No certificates found for this product.
Compound Information
Technical specifications
Lyophilized powder; keep sealed, dry, and protected from light
Store at a stable temperature and minimize warming/cooling cycles
After reconstitution, avoid repeated freeze–thaw cycles
Lyophilized Powder
-20°C
Reconstituted
2–8°C
Retatrutide is a specialized synthetic peptide researched for its ability to function as a triple agonist, targeting the GLP-1, GIP, and Glucagon receptors simultaneously. This compound is of significant interest in metabolic research for investigating how the activation of three distinct receptor pathways can influence energy expenditure and weight regulation. Supplied as a stable lyophilized powder, it provides a consistent reagent for in-vitro and approved in-vivo studies in animals. This product is strictly for laboratory research and development purposes and must be handled by qualified professionals only.
It is a triple agonist researched for its simultaneous interaction with GLP-1, GIP, and Glucagon receptors.
No, this product has not been evaluated by the FDA and is strictly intended for research and development purposes by qualified professionals only.
